Journal of Molecular Biomarkers and Clinical Trials

Nanotechnology for Biomarkers or Biomarkers for Nanotechnology in Medical Approaches: What Can We Anticipate?

Published on: 2015-06-27


In recent years, there has been excitement about the ability to predict the future disease risk factor status. For this purpose, biomarkers have been used in pre-clinical research and clinical diagnosis. The National Institute of Health Biomarkers Definitions Working Group has defined a biomarker as a measurable indicator of some normal biological processes, pathogenic processes, or pharmacological responses and toxicological effects of a therapeutic intervention. Biomarkers can be of various molecular origins, including nucleic acid (DNA or RNA), protein (enzymes or antibodies), or a substance introduced into the body to assess how an organ, tissue, or system is functioning.


Biomarkers, Nanobiosensors, Nanomaterials, Nanotoxicity